Department of Biotechnology supports production scale-up of test kits from Mylab

Pune, July 25, 2020: Pune-based Mylab Discovery
Solutions has scaled up its production and development
of COVID-19 pathodetect testing kit
with the help of strategic funding under the
National Biopharma Mission of Department of
Biotechnology (DBT)-Biotechnology Industry
Research Assistance Council (BIRAC).
Hasmukh Rawal, MD, Mylab Discovery
Solutions said, “We are very thankful to
Biotechnology Industry Research Assistance
Council for hand holding us when no one
believed us. With the funds we would really be
able to accelerate our process of the production.”
Dr Renu Swarup, Secretary, DBT and
Chairperson BIRAC said, “In our fight against
the current pandemic, having indigenous supplies
of qualitative RT-PCR test kits was identified
as a critical need in enhancing the testing
ability across the country. Therefore scale-up of
Mylab’s pathodetect production was a step DBT
took very early in that direction. This production
line at Mylab manufactures rapid, high throughput
detection platform and is aligned with our
Prime Minister’s vision of AtmaNirbhar Bharat.”
Currently, Mylab has a manufacturing capacity
of 2,00,000 RT-PCR and 50,000 RNA tests.
Mylab has obtained CDSCO/India-FDA and
ICMR approval to manufacture for NAT, HIV,
HBV, HCV and for detection of novel coronavirus
2019-n COV/SARS-COV-2.
The company has recently launched a
Molecular laboratory machine Compact XL that
can manufacture various reagents as well as perform
many molecular tests in a single machine
unit.
The Compact XL will help India in setting up
a number of Molecular Diagnostic labs in rural
India as it eliminates huge infrastructure costs,
Capex and Opex costs as a minimal number of
employees can easily do a large number of
tests.

Leave a Reply

Your email address will not be published. Required fields are marked *

United Newspapers, 3727, Sector 46 c, Chandigarh 160047.

Email: going46@gmail.com

Mobile: 9815047017